EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pretransplant screening and lower incidence of breast and prostate cancers among organ transplant recipients in the United States

Shyfuddin Ahmed iD, Michael J Silverberg iD, Eric A Engels iD

JNCI Cancer Spectrum · 2025

DOI: 10.1093/jncics/pkaf080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2025. Verfasst von Shyfuddin Ahmed und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20892, United States. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Breast Neoplasms, Early Detection of Cancer, Organ Transplantation. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Solid organ transplant recipients (SOTRs) in the United States have lower risks for breast and prostate cancers than the general population. To explore whether pretransplant screening explains this observation, we conducted a case-control study of US adults aged 65 years or older using the SEER-Medicare database (2000-2019). We included 252 279 breast cancer cases, 3 855 275 female controls, 316 981 prostate cancer cases, and 2 361 846 male controls. We used Medicare claims to identify solid organ transplant procedures and screening with mammography or prostate-specific antigen testing before case/control selection. SOTRs exhibited reduced risks for breast cancer (adjusted odds ratio = 0.60, 95% CI = 0.45 to 0.80) and prostate cancer (0.84, 95% CI = 0.71 to 1.00). These inverse associations were significant among screened individuals, although a borderline association for breast cancer was suggested in unscreened women. Pretransplant cancer screening probably largely explains the reduced risks of breast and prostate cancer among US SOTRs, but there may also be other protective factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBreast NeoplasmsEarly Detection of CancerOrgan TransplantationTransplant RecipientsHumansMaleAgedFemaleUnited StatesCase-Control StudiesSEER ProgramIncidenceProstate-Specific AntigenMedicareMammographyAged, 80 and over

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20892, United States.
  • Division of Research, Kaiser Permanente Northern California, Pleasanton, CA 94588, United States.

ORCID-Profile: Shyfuddin Ahmed, Michael J Silverberg, Eric A Engels

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Ahmed, S., Silverberg, M. J., & Engels, E. A. (2025). Pretransplant screening and lower incidence of breast and prostate cancers among organ transplant recipients in the United States. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkaf080

Vancouver

Ahmed S, Silverberg MJ, Engels EA. Pretransplant screening and lower incidence of breast and prostate cancers among organ transplant recipients in the United States. JNCI Cancer Spectrum. 2025. doi:10.1093/jncics/pkaf080

BibTeX
@article{Ahmed2025,
  author = {Ahmed, Shyfuddin and Silverberg, Michael J and Engels, Eric A},
  title = {Pretransplant screening and lower incidence of breast and prostate cancers among organ transplant recipients in the United States},
  journal = {JNCI Cancer Spectrum},
  year = {2025},
  doi = {10.1093/jncics/pkaf080}
}
Kostenlos starten →